![logo2](/ServeContent?url=http%3A%2F%2Fwww.heterocycles.jp%2Fclockss%2Fimg%2Fcycle.gif)
![logo2](/ServeContent?url=http%3A%2F%2Fwww.heterocycles.jp%2Fclockss%2Fimg%2Flogo_box.gif)
HETEROCYCLES
An International Journal for Reviews and Communications in Heterocyclic ChemistryWeb Edition ISSN: 1881-0942
Published online by The Japan Institute of Heterocyclic Chemistry
e-Journal
Full Text HTML
Received, 4th May, 2010, Accepted, 2nd June, 2010, Published online, 3rd June, 2010.
DOI: 10.3987/COM-10-S(E)26
■ Silver-Catalyzed Oxidative Coupling of Terminal Aromatic Alkynes and Benzylic Ethers
Camille A. Correia and Chao-Jun Li*
Department of Chemistry, McGill University, 801 Sherbrooke St. West, Montreal, Quebec H3A 2K6, Canada
Abstract
The Cross-Dehydrogenative-Coupling (CDC) of terminal aromatic alkynes and benzylic ethers was achieved through the use of a catalytic amount of silver triflate and employing 2,3-dichloro-5,6-dicyanoquinone (DDQ) as the oxidant.INTRODUCTION
Direct C-C bond formation through metal catalyzed C-H bond activation continues to attract interest as it provides organic chemists with an alternative to traditional functional group derivatization for organic synthesis.1 This allows for better atom economy and reduces the number of steps in the synthetic process.2 In an effort to completely eliminate highly functionalized starting material our group has focused on the development by direct activation of simple starting material. The method of activation and subsequent coupling of C-H bonds in both substrates was termed Cross-Dehydrogenative-Coupling (CDC).3,4
Among the strategies for activation of the sp C-H bond of terminal alkynes, there are few reports of using silver for in situ generation of acetylides.5 Previously, our group has published reports showing Ag (I) to be an effective catalyst for the nucleophilic addition of terminal alkynes to C=O and C=N bonds.6 To our knowledge the oxidative coupling of alkynes and benzylic ethers has not yet been reported. Herein, we report the first silver-catalyzed sp-sp3 CDC reaction of terminal aromatic alkynes and benzylic ethers (Scheme 1).
RESULTS AND DISCUSSION
We chose isochroman (1a) and phenylacetylene (2a) as the standard substrates for the optimization of reaction conditions. 2,3-Dichloro-5,6-dicyanoquinone (DDQ)7 was employed as the oxidant since we8 and others9 have had previous success using it for C-H activation reactions. To begin our study we initially tested 5 mol% each of AuClPPh3 and AgOTf under neat conditions at 120 oC, which produced the desired compound (3a) in a 17% yield (Table 1, entry 1). The product yield could be increased to 34% when the reaction was run in 0.5 mL chlorobenzene (C6H5Cl) at 120 oC (entry 2). When AgOTf was removed, AuClPPh3 could only furnish the product in a 22% yield. Surprisingly using AgOTf as the lone catalyst the yield jumped to 59% (entry 5). A comparable yield could be obtained at a milder temperature of 70 oC in 1.0 mL dichloroethane (DCE) (entry 6); however it could not be further optimized at this temperature. A better yield of 73% was obtained when the reaction was run in 2.0 mL toluene at 120 oC; we could get the same yield at lower catalyst loading of 2.5 mol% (entries 7 and 8). The addition of 0.5 mL of the more polar solvent chlorobenzene was found to be beneficial to the reaction (entry 9).10 Changing the metal catalyst to 1 mol% copper (II) triflate, 3a was produced in comparable yields to our best conditions (entries 9 and 12). However, when we turned to the scope of the reaction, silver triflate was found to provide better NMR yields for functionalized alkynes such as 3-fluorophenylacetylene. The best condition was obtained when the reaction was performed on a 0.1 mmol scale (entry 13). The silver catalyst is instrumental to the reaction; 3a was not obtained when the catalyst was removed from the reaction mixture (entry 10).
With our best conditions, as set out in Table 1 entry 13, we then examined the scope of the reaction (Table 2). Phenylacetylene was found to be the best substrate affording the corresponding product (3a) in high yield (entry 1). Weakly donating or withdrawing groups provided the product in moderate to good yields. Aromatic alkynes with strong donating groups (2h,i) were also feasible and the corresponding products were obtained in moderate yields. Gratifyingly, it was also possible to use strong withdrawing groups such as m-F and p-CF3 (2d,e); however owing to their reduced reactivity yields were only moderate.11 Isochroman appeared to be the best benzylic ether substrate for this reaction. Although the reaction could also be realized with the acyclic methyl benzyl ether, poor yields were obtained (entries 11 and 12). Dibenzyl sulfide was not reactive under these conditions.
The reaction is likely initiated by a single electron transfer from isochroman to DDQ to form the radical cation 4. H-radical abstraction from 4 would yield the highly reactive benzoxy cation intermediate 5.12 In the presence of silver triflate, the reduced hydroquinone anion can react with phenyl acetylene producing the silver acetylide 6 which would then add to 5 to form the product 3a (Scheme 2).
In summary, we developed a novel silver-catalyzed sp-sp3 Cross-Dehydrogenative-Coupling of terminal aromatic alkynes and benzylic ethers utilizing DDQ as the oxidant. The in-situ generated acetylide is formed under low catalyst loadings and the CDC reaction allows direct use of the alkyne and ether which are simple starting materials. The application and further expansion of the scope of this reaction is still under investigation.
EXPERIMENTAL
Typical Procedure: AgOTf (0.0025 mmol) and DDQ (0.15 mmol) was placed in a sealable tube. To this 1 mL toluene and 0.25 mL chlorobenzene, phenylacetylene (0,1 mmol) and isochroman (0.5 mmol) were then added. The tube was sealed and flushed with argon, then stirred for 16 h at 120 oC. The reaction mixture was cooled to room temperature and flushed through a short column of silica gel with EtOAc. The solvent was then removed under vacuum. The product was isolated from the dark purple crude mixture by flash column chromatography using CH2Cl2.13
1-(2-Phenylethynyl)-3,4-dihydro-1H-isochromene (3a). 1H NMR (500 MHz, CDCl3, ppm) δ 7.51-7.49 (m, 2H), 7.40-7.39 (m, 1H), 7.36-7.32 (m, 3H), 7.30-7.25 (m, 2H), 7.19-7.18 (m, 1H), 5.82 (s, 1H), 4.38-4.33 (m, 1H), 4.07 (dt, J = 5.4 Hz, 11.5 Hz, 1H), 3.02-2.90 (m, 2H); 13C NMR (125 MHz, CDCl3, ppm) δ 135.0, 132.8, 131.9, 129.0, 128.5, 128.2, 127.3, 126.4, 126.1, 122.6, 88.1, 85.7, 67.3, 62.7, 28.1; HRMS (ESI): m/z: [M-H]+ calculated for C17H13O: 233.09609; found: 233.09616.
1-(2-(4-Butylphenyl)ethynyl)-3,4-dihydro-1H-isochromene (3b). 1H NMR (500 MHz, CDCl3, ppm) δ 7.37-7.34 (m, 3H), 7.23-7.21 (m, 2H), 7.15-7.13 (m, 1H), 7.11 (d, J = 8.1 Hz, 2H), 5.77 (s, 1H), 4.33-4.29 (m, 1H,), 4.02 (dt, J = 5.4 Hz, 14.5Hz, 1H), 2.97-2.86 (m, 2H) 2.59 (t, J = 7.8 Hz, 2H), 1.63-1.55 (m, 2H), 1.34 (q, J = 7.4 Hz, 2H), 0.92 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3, ppm) δ 143.6, 135.1, 132.8, 131.8, 128.9, 128.3, 127.2, 126.3, 126.1, 119.7, 87.4, 85.9, 67.4, 62.7, 35.5, 33.4, 28.1, 22.3, 13.9; HRMS (ESI): m/z: [M-H]+ calculated for C21H21O: 289.15869; found: 289.15873.
1-(2-(4-Tert-butylphenyl)ethynyl)-3,4-dihydro-1H-isochromene (3c). 1H NMR (500 MHz, CDCl3, ppm) δ 7.39 (d, J = 8.5 Hz, 2H), 7.37-7.31 (m, 3H), 7.24-7.21 (m, 2H), 7.16-7.13 (m, 1H), 5.77 (s, 1H), 4.34-4.29 (m, 1H), 4.02 (dt, J = 5.4 Hz, 14.5 Hz, 1H), 2.97-2.87 (m, 2H), 1.30 (s, 9H); 13C NMR (125 MHz, CDCl3, ppm) δ 151.7, 135.1, 132.8, 131.6, 128.9, 127.2, 126.3, 126.1, 125.2, 119.5, 87.4, 85.8, 67.4, 62.7, 34.8, 31.1, 28.1; HRMS (ESI): m/z: [M-H]+ calculated for C21H21O: 289.15869; found: 289.15866.
1-(2-(3-Fluorophenyl)ethynyl)-3,4-dihydro-1H-isochromene (3d). 1H NMR (500 MHz, CDCl3, ppm) δ 7.39-7.31 (m, 1H), 7.29-7.22 (m,4H), 7.16-7.14 (m, 2H), 7.04-7.02 (m, 1H), 5.77 (s, 1H), 4.32-4.27 (m, 1H), 4.04 (dt, J = 5.4 Hz, 11.5 Hz, 1H), 2.98-2.86 (m, 2H) ; 13C NMR (125 MHz, CDCl3, ppm) δ 162.3 (d, J = 245.1 Hz), 134.6, 132.8, 129.8 (d, J = 8.8 Hz ), 129.0, 127.7 (d, J = 3.3 Hz), 127.3 126.4, 125.9, 124. 3 (d, J = 9.8 Hz), 118.6 (d, J = 23.1 Hz), 115.8 (d, J = 21.2 Hz), 89.1, 84.4 (d, J = 3.3 Hz), 67.2, 62.7, 28.0; HRMS (ESI): m/z: [M-H]+ calculated for C17H12FO: 251.08667; found: 251.08661.
1-(2-(4-(Trifluoromethyl)phenyl)ethynyl)-3,4-dihydro-1H-isochromene (3e). 1H NMR (500 MHz, CDCl3, ppm) δ 7.56 (s, 4H), 734-7.32 (m, 1H), 7.25-7.24 (m, 2H), 7.17-7.15 (m, 1H), 5.79 (s, 1H), 4.32-4.27 (m, 1H), 4.05 (dt, J = 5.4Hz, 11.5 Hz, 1H), 2.99-2.87 (m, 2H); 13C NMR (125 MHz, CDCl3, ppm) δ 134.4, 132.8, 132.1, 130.2 (q, J = 32.4 Hz), 129.1, 127.4, 126.6, 126.5, 125.9, 125.2 (q, J = 3.8 Hz), 123.8 (q, J = 270.6 Hz), 90.6, 84.2, 67.1, 62.8, 28.0; HRMS (ESI): m/z: [M-H]+ calculated for C18H12F3O: 301.08348; found: 301.08346.
1-(2-p-Biphenylethynyl)-3,4-dihydro-1H-isochromene (3f). 1H NMR (500 MHz, CDCl3, ppm) δ 7.59 (d, J = 7.1 Hz, 2H), 7.54 (s, 4H), 7.45 (t, J = 7.8 Hz, 2H), 7.39-7.36 (m, 2H), 7.26-7.24 (m, 2H), 7.17-7.16 (m, 1H), 5.82 (s, 1H), 4.36-4.32 (m, 1H), 4.05 (dt, J = 5.4 Hz, 11.5 Hz, 1H), 3.0-2.88 (m, 2H); 13C NMR (125 MHz, CDCl3, ppm) δ 141.2, 140.3, 134.9, 132.8, 132.3, 129.0, 128.8, 127.7, 127.3, 127.0, 126.9, 126.4, 126.1, 121.5, 88.8, 85.6, 67.4, 62.7, 28.1; HRMS (ESI): m/z: [M-H]+ calculated for C23H17O: 309.12739; found: 309.12744.
1-(2-p-Tolylethynyl)-3,4-dihydro-1H-isochromene (3g). 1H NMR (500 MHz, CDCl3, ppm) δ 7.34 (d, 3H, J = 8.1 Hz), 7.24-7.20 (m, 2H), 7.18-7.13 (m, 1H), 7.10 (d, 8.5 Hz, 2H), 5.76 (s, 1H), 4.33-4.28 (m, 1H), 4.02 (dt, J = 5.4 Hz, 11.5 Hz, 1H), 2.96-2.86 (m, 2H), 2.34 (s, 3H); 13C NMR (125 MHz, CDCl3, ppm) δ 138.6, 135.1, 132.8, 131.7, 128.9, 128.9, 127.2, 126.3, 126.1, 119.5, 87.3, 85.8, 67.4, 62.7, 28.1, 21.5; HRMS (ESI): m/z: [M-H]+ calculated for C18H15O: 247.11174; found: 247.11149.
1-(2-(4-Methoxyphenyl)ethynyl)-3,4-dihydro-1H-isochromene (3h). 1H NMR (500 MHz, CDCl3, ppm) δ 7.41-7.7.38 (m, 2H), 7.36-7.34 (m, 1H), 723-7.22 (m, 2H), 7.15-7.13 (m, 1H), 6.84-6.81 (m, 2H), 5.76 (s, 1H), 4.33-4.28 (m, 1H), 4.02 (dt, J = 5.2 Hz, 11.7 Hz, 1H), 2.99-2.86 (m, 2H), 3.80 (s, 3H); 13C NMR (125 MHz, CDCl3, ppm) δ 159.7, 135.2, 133.3, 132.8, 128.9, 127.1, 126.3, 126.1, 114.6, 113.8, 86.7, 85.6, 67.4, 62.7, 55.3, 28.1; HRMS (ESI): m/z: [M+H]+ calculated for C18H17O2: 265.12231; found: 265.12233.
1-(2-(4-Phenoxyphenyl ethynyl)-3,4-dihydro-1H-isochromene (3i). 1H NMR (500 MHz, CDCl3, ppm) δ 7.42 (d, J = 8.8 Hz, 2H), 7.37-7.34 (m, 3H), 7.24-7.22 (m, 2H), 7.16-7.14 (m, 2H), 7.02 (d, J = 7.6 Hz, 2H), 6.92-6.91 (m, 2H), 5.77 (s, 1H), 4.33-4.29 (m, 1H), 4.03 (dt, J = 5.2 Hz, 11.7 Hz, 1H), 2.98-2.87 (m, 2H); 13C NMR (125 MHz, CDCl3, ppm) δ 157.8, 156.4, 133.5, 132.8, 129.9, 129.0, 127.2, 126.4, 123.9, 119.4, 118.2, 117.2, 117.1, 87.4, 85.2, 67.4, 62.7, 28.1; HRMS (ESI): m/z: [M+H]+ calculated for C23H19O2 : 327.13796; found: 327.13800.
1-(2-(6-Methoxynaphthalen-2-yl)ethynyl)-3,4-dihydro-1H-isochromene (3j). 1H NMR (500 MHz, CDCl3, ppm) δ 7.91 (s, 1H), 7.66 ( t, J= 9.6 Hz, 2H), 7.47 (dd, J = 8.3, 1.5 Hz, 1H), 7.41-7.39 (m, 1H), 7.25-7.24 (m, 2H), 7.17-7.13 (m, 2H), 7.09(d, J = 2.4 Hz, 1H), 5.82 (s, 1H), 4.37-4.32 (m, 1H), 4.05 (dt, J = 5.4 Hz, 11.5 Hz, 1H), 3.92 (s, 3H), 2.99-2.88 (m, 2H); 13C NMR (125 MHz, CDCl3, ppm) δ 158.4, 135.1, 134.2, 132.8, 131.7, 129.3, 129.1, 129.0, 128.3, 127.2, 126.7, 126.4, 126.1, 119.4, 117.4, 105.8, 87.7, 86.2, 67.4, 62.7, 55.3, 28.1; HRMS (ESI): m/z: [M+H]+ calculated for C22H19O2: 315.13796; found: 315.13801.
3-Methoxy-(1-diphenyl)(3-phenyl)prop-1-yne (3l). 1H NMR (500 MHz, CDCl3, ppm) δ 7.60-7.58 (m, 3H), 7.56 (s, 3H), 7.46-7.35 (m, 8H), 5.34 (s, 1H), 3.51 (s, 3H); 13C NMR (125 MHz, CDCl3, ppm) δ 140.3, 138.5, 132.2, 128.9, 128.5, 128.5, 127.7, 127.5, 127.0, 127.0, 126.8, 121.4, 87.6, 87.3, 73.6, 56.0; HRMS (ESI): m/z: [M+H]+ calculated for C22H19O : 299.14304; found: 299.14310.
ACKNOWLEDGEMENTS
We are grateful to the Canada Research Chair (Tier 1) foundation (to C-J Li), CFI, FQRNT and NSERC for their support to this research. C.A.C. would also like to thank McGill University for the Principal’s Graduate Fellowship.
References
1. For recent reviews, see: (a) R. G. Bergman, Nature, 2007, 446, 391; CrossRef (b) C. Jia, T. Kitamura, and Y. Fujiwara, Acc. Chem. Res., 2001, 34, 633; CrossRef (c) V. Ritleng, C. Sirlin, and M. Pfeffer, Chem. Rev., 2002, 102, 1731; CrossRef (d) G. Dyker, Handbook of C-H Transformations; Wiley-VCH: Weinheim, 2005; CrossRef (e) K. Godula and D. Sames, Science, 2006, 312, 67; CrossRef (f) J.-Q. Yu, R. Giri, and X. Chen, Org. Biomol. Chem., 2006, 4, 4041; CrossRef (g) D. Alberico, M. E. Scott, and M. Lautens, Chem.Rev., 2007, 107, 174; CrossRef (h) C. Herrerias, X. Yao, Z. Li, and C.-J. Li, Chem. Rev., 2007, 107, 2546. CrossRef
2. (a) P. T. Anastas and J. C Warner, Green Chemistry: Theory and Practice, Oxford University Press, New York, 1998; (b) C.-J. Li and B. M. Trost, Proc. Natl. Acad. Sci. USA, 2008, 105, 13197. CrossRef
3. For reviews, see: (a) C.-J. Li, Acc. Chem. Res., 2009, 42, 335; CrossRef (b) C. J. Scheuermann, Chem. Asian J., 2010, 5, 436. CrossRef
4. For recent CDC reactions: (a) J. Jin, Y. Li, Z.-J. Wang, W.-X. Qian, and W.-L. Bao, Eur. J. Org. Chem., 2010, 1235; CrossRef (b) C. U. Maheswari, G. S. Kumar, M. Venkateshwar, R. A. Kumar, M. L. Kantam, and K. R. Reddy, Adv. Synth. Catal., 2010, 352, 341; CrossRef (c) C. A. Correia and C.-J. Li, Tetrahedron Lett., 2010, 51, 1172; CrossRef (d) Y. Wei, H. Zhao, J. Kan, W. Su, and M. Hong, J. Am. Chem. Soc., 2010, 132, 2522; CrossRef (e) L. Zhao, O. Basle, and C.-J. Li, Proc. Nat. Acad. Sci. USA, 2009, 106, 4106; CrossRef (f) X. Guo, G. Deng, and C.-J. Li, Adv. Synth. Catal., 2009, 351, 2071; CrossRef (g) G. Deng and C.-J. Li, Org. Lett., 2009, 11, 1171; CrossRef (h) A. Yu, Z. Gu, D. Chen, W. He, P. Tan, and J. Xiang, Catal. Commun., 2009, 11, 162; CrossRef (i) Z. Li, X. Guo, R. Yu, and H. Li, J. Am. Chem. Soc., 2009, 131, 17387; CrossRef (j) B. Liegault and K. Fagnou, Organometallics, 2008, 27, 4841; CrossRef (k) T. Dohi, M. Ito, K. Morimoto, M. Iwata, and Y. Kita, Angew Chem. Int. Ed., 2008, 47, 1301; CrossRef (l) B.-J. Li, S.-L. Tian, Z. Fang, and Z.-J. Shi, Angew Chem. Int. Ed., 2008, 47, 1115. CrossRef
5. Silver as a stoichiometric reagent: (a) S. Dillinger, P. Bertus, and P. Pale, Org. Lett., 2001, 3, 1661; CrossRef Catalytic silver (b) D. Ye, X. Zhang, Y. Zhou, D. Zhang, L. Zhang, H. Wang, H. Jiang, and H. Liua, Adv. Synth. Catal., 2009, 351, 2770; CrossRef (c) R. Maggi, A. Bello, C. Oro, G. Sartori, and L. Soldi, Tetrahedron, 2008, 64, 1435; CrossRef (d) M. Rueping, A. P. Antonchick, and C. Brinkmann, Angew. Chem., Int. Ed., 2007, 46, 6903; CrossRef (e) Z. Chen, X. Yan, and J. Wu, Chem. Commun., 2009, 3469; CrossRef (f) X. Ji, T. T.-L. Au-Yeung, J. Wu, C. W. Yip, and A. S. C. Chan, Adv. Synth. Catal., 2004, 346, 42. CrossRef
6. (a) C. Wei and C.-J. Li, Green Chem., 2002, 4, 39; CrossRef (b) X. Yao and C.-J. Li, Org. Lett., 2005, 7, 4395; CrossRef (c) M. Yu, R. Skouta, L. Zhou, H.-F. Jiang, X. Yao, and C.-J. Li, J. Org. Chem., 2009, 74, 3378; CrossRef (d) G. Deng and C.-J. Li, Synlett, 2008, 1571; CrossRef (e) C. M. Wei, Z. G. Li, and C.-J. Li, Org. Lett., 2003, 5, 4473; CrossRef (f) Z. Li, C. Wei, L. Chen, R. S. Varma, and C.-J Li, Tetrahedron Lett., 2004, 45, 2443; CrossRef (g) B. Huang, X. Yao, and C.-J. Li, Adv. Synth. Catal., 2006, 348, 1528. CrossRef
7. D. Walker and J. D. Hiebert, Chem. Rev., 1967, 67, 153. CrossRef
8. (a) Y. Zhang and C.-J. Li, Angew. Chem. Int. Ed., 2006, 45, 1949; CrossRef (b) Y. Zhang and C.-J. Li, J. Am. Chem. Soc., 2006, 128, 4242. CrossRef
9. (a) Z.-J. Shi, S. Lin, X.-Y. Lu, B.-J. Li, and Y.-Z. Li, Angew. Chem. Int. Ed., 2009, 48, 3817; CrossRef (b) X. She, X. Pan, Y. Su, J. Li, T. Jiang, and B. Yu, Org. Lett., 2009, 11, 2603; CrossRef (c) W. Bao and D. Cheng, J. Org. Chem., 2008, 73, 6881; CrossRef (d) W. Bao and D. Cheng, Adv. Synth. Catal., 2008, 350, 1263; CrossRef (e) B.-P. Ying, B. G. Trogden, D. T. Kohlman, S. X. Liang, and Y.-C. Xu, Org. Lett., 2004, 6, 1523. CrossRef
10. We do not know the exact reason for increased performance when a 4:1 mixture of toluene:chlorobenzene was used as opposed to pure toluene. However, we think it may be due to increased solubility of DDQ.
11. The isolated yields for 3d and 3e were obtained when 0.5 mL chlorobenzene was used as the solvent. When the standard conditions of 1.2 mL 4:1 toluene:chlorobenzene was used a lower yield was observed.
12. D. Hermeling, Ger. Offen. DE 4201544, A1 19930729, 1993, p. 5.
13. Characterization for compound 3i: M. Hayashi, A. Inubushi, and T. Mukaiyama, Bull. Chem. Soc. Jpn., 1988, 61, 4037. CrossRef